Wagner M, Goetghebeur M, Merikle E, Pandya A, Chu P, Taylor DC. COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA. J Popl Ther Clin Pharmacol [Internet]. 2018 Dec. 8 [cited 2024 Nov. 19];16(2). Available from: https://mail.jptcp.com/index.php/jptcp/article/view/549